Multi-Disciplinary Organization Dedicated to Promoting Advances in
Neuro-Oncology Through Research and Education

WFNOS Magazine

The inaugural issue of the official publication of the World Federation of Neuro-Oncology Societies is ...

Read Full Story

Neuro-Oncology Review Course at SNO

November 16, 2016. Register in conjunction with the SNO Annual Meeting

Read Full Story

CNS Anticancer Drug Discovery and Development Conference

Register Now!

Read Full Story
View All News

October
12

EANO 2016

Read Full Story

October
22

18th Annual Brain Tumor Update and 7th Annual International Symposium on Long-Term Control of Metastases to the Brain and Spine

Read Full Story

November
16

2nd CNS Anticancer Drug Discovery/Development Conference

Read Full Story

Ependymoma Network

Translational and clinical research on ependymomas
 
With generous philanthropic support, CERN (Collaborative Ependymoma Research Network) has been formed to focus research efforts on this rare tumor, and, through international collaborations, to acquire sufficient tumor material for analysis and accrue patients to clinical trials, to promote progress against adult and/or pediatric ependymoma. With coordinating centers at M. D. Anderson Cancer Center (under Mark Gilbert) and St. Jude Children’s Research Hospital (under Richard Gilbertson), CERN encompasses an additional 9 clinical centers in the US and Canada to maximize patient access, with the potential for adding more centers and accept patient referrals to extend this benefit. Projects range from stem cell biology and generation of ependymoma mouse models, to tumor tissue profiling, molecular drug target identification and targeted drug development, to a clinical trials network to quickly capitalize on findings. Additional information is available at http://www.cern-foundation.org.